A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trialDaisuke Tomizawa, Katsuyoshi Koh, Takako Miyamura et al.|Blood|2020Cited by 102
Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in JapanToshihiko Imamura, Hiroyuki Shimada, Nobutaka Kiyokawa et al.|Blood Cancer Journal|2016Cited by 68
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemiaTomoya Isobe, Berthold Göttgens, Hiroo Ueno et al.|Nature Communications|2022Cited by 36
JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALLMotohiro Kato, Katsuyoshi Koh, Yasuhiro Okamoto et al.|Journal of Clinical Oncology|2024Cited by 16
Nationwide study of pediatric B‐cell precursor acute lymphoblastic leukemia with chromosome 8q24/<i>MYC</i> rearrangement in JapanKimiyoshi Sakaguchi, Katsuyoshi Koh, Toshihiko Imamura et al.|Pediatric Blood & Cancer|2020Cited by 11